Neil Brewis

Chief Scientific Officer, F-star Therapeutics, Inc.

Companies

F-star Therapeutics, Inc.Chief Scientific Officer Nov 24, 2020 to Mar 9, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

F-star Therapeutics, Inc.0 shares²Mar 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 8, 2023Returned to company 9,375 shares at $7.12 of F-star Therapeutics, Inc.²
Mar 8, 2023U 105,088 shares at $7.12 of F-star Therapeutics, Inc.²
Jul 29, 2022Exercised options 76,619 shares at $0.11 of F-star Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARF-star Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARF-star Therapeutics, Inc. shares after the filing of Mar 8, 2023
3
SEC EDGARForm 4 filed Aug 2, 2022